Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERFECT: Ingenol Mebutate for Actinic Keratosis in Korean Patients
NCT02716714Phase 4Completed
- Sponsor
- Korea University
- Start
- Apr 2015
- Primary completion
- Jun 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Korea University. Started Apr 2015; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02716714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02716714.